tissuechip.com
The category name for living tissue on a chip, as one clean .com.
A tissue chip is a small microfluidic device lined with living cells, built to mimic aspects of how a human tissue works while fluid flows through its tiny channels. TissueChip.com gives a platform, lab or tools company the plain name people already use.
- Extension
- .comthe default commercial TLD
- Characters
- 10
- Words
- 2tissue + chip
- Hyphens / numbers
- Noneletters only, no hyphens
- Match / brand type
- Exact termcategory keyword
- Status
- Available
The name of the device, not a description of it.
Tissue chip is the plain-language term for this class of device in research and industry. TissueChip.com owns it in ten letters.
What a tissue chip is, and why the term is worth owning.
Where the phrase comes from, what the devices do, and what is still unsolved. Sourced throughout.
From a flat dish to a perfused device
A tissue chip is a small engineered device, usually built around microfluidic channels, where living human cells behave more like tissue in a body than cells in a well plate. NIH calls them devices "built from human cells" that "mimic the structure and function of our heart, kidneys, lungs and other organ systems".1 Ordinary culture is a flat, static monolayer. What defines a chip is cells "cultured under fluid flow", lifting a model from cell behaviour to organ-level physiology.3
Tissue chip, organ chip, tissue-on-a-chip
Tissue chip is the word NIH uses, and the word the FDA uses on its qualification pages.19 Organ-on-a-chip arrived with the 2010 Science paper that started the field.4 Microphysiological system, or MPS, is the formal register.5 Tissue-on-a-chip and tissue-on-chip are longer spellings, settled by ASTM terminology standard F3570-22 of July 2022.6
How a tissue chip differs from an organoid
An organoid is defined by its cells: a 2019 Science review calls organoids "stem cell-derived, self-organizing miniature organs".7 A tissue chip is defined by its device: channels, flow, barriers and built-in readouts. The same review asks for "engineering approaches for the production, control, and analysis of organoids and their microenvironment".7 The two combine, since organoids are often the tissue inside a chip.
The programme that made the phrase standard
Work "began in 2010 as a five-year partnership among NIH, the Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug Administration (FDA)", and NCATS has led it since 2012.8 The aim is "bioengineered devices to improve the process of predicting whether drugs will be safe or toxic in humans".1 Four strands grew from it:
- Independent validation. Centres at independent institutions "test and validate tissue chip platforms";10 four translational centres were funded in 2024.11
- Disease models, rare ones included — paediatric disorders, kidney, heart and liver disease, premature aging, premature birth.12
- Immune modelling, with the National Institute of Biomedical Imaging and Bioengineering.10
- Chips in orbit, where reduced gravity accelerates ageing-like change in human muscle tissue.13
What tissue chips are used for
- Toxicity and safety. A blinded study of 870 liver chips against 27 known hepatotoxic and non-toxic drugs reported "a sensitivity of 87% and a specificity of 100%".14
- Disease and rare disease, where patient cells are scarce and animal models often absent.3
- Immune and host–microbiome response, plus reactions to pathogens, radiation and toxins.3
- Pharmacokinetics. A 2022 multi-organ system "recapitulated the pharmacokinetic and pharmacodynamic profiles" of a chemotherapy drug in humans.15
Qualification: from device to accepted tool
The FDA Modernization Act 2.0, approved on 29 December 2022, replaced "preclinical tests (including tests on animals)" in United States drug law with "nonclinical tests", a defined term whose list names "Organ chips and microphysiological systems".16 Animal tests remain item five, so nothing was banned. A qualification route exists: the FDA's ISTAND pilot names the "use of tissue chips (i.e., microphysiological systems) to assess safety or efficacy questions".9 The agency's April 2025 roadmap on animal testing devotes a section to in vitro human-derived systems.17
Standards and reproducibility: the unfinished part
A 2025 US Government Accountability Office assessment found these devices "cannot replace animal testing but may be used alongside animals", naming the obstacles: companies reported that "only 10 percent to 20 percent of human cells they purchase are high enough quality"; benchmarks are lacking; data sharing is limited.18 A 2021 analysis called for an "extensive qualification process".19 A 2024 paper put it squarely: "MPS complexity introduces standardization challenges, impacting reproducibility and trust."2 That is work, not a dead end.
Who builds around a name like this
- Device and platform companies making chips, pumps, plates and imaging.
- Contract research and testing laboratories selling nonclinical studies on human-cell models.16
- Pharmaceutical safety and drug-disposition groups.5
- Consortia, societies, standards groups and conferences.6
- Cell, media and consumable suppliers, since cell quality is a measured bottleneck.18
- Academic centres, courses and publishers, where validation and protocols are the product.11
Sources are named to credit facts, not to imply any relationship or endorsement. This is a domain sale page; it does not provide medical advice or services.
- Tissue Chip for Drug Screening.NCATS, NIH
- Pamies D et al. Fit-for-purpose criteria for quality management of microphysiological systems.Stem Cell Reports, 2024
- Ingber DE. Human organs-on-chips for disease modelling, drug development and personalized medicine.Nature Reviews Genetics, 2022
- Huh D et al. Reconstituting organ-level lung functions on a chip.Science, 2010
- Baker TK et al. Use of microphysiological systems by the pharmaceutical industry.Drug Metabolism and Disposition, 2024
- ASTM F3570-22, Standard Terminology Relating to Microphysiological Systems.ASTM International, July 2022
- Park SE, Georgescu A, Huh D. Organoids-on-a-chip.Science, 2019
- Tissue Chip Program Collaborations and Partnerships.NCATS, NIH
- Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.U.S. Food and Drug Administration
- Tissue Chip Projects & Initiatives.NCATS, NIH
- NIH-funded centers look to make tissue chips FDA-ready tools.NCATS news, 25 July 2024
- Clinical Trials on a Chip: awards for bioengineered organ models.NCATS news, 29 September 2020
- Tissue chips and age-related muscle loss in microgravity.ISS National Laboratory, Upward, 29 August 2024
- Ewart L et al. Performance assessment of a human Liver-Chip for predictive toxicology.Communications Medicine, 2022
- Ronaldson-Bouchard K et al. A multi-organ chip with matured tissue niches linked by vascular flow.Nature Biomedical Engineering, 2022
- Public Law 117-328, Section 3209: the FDA Modernization Act 2.0.Approved 29 December 2022
- Roadmap to Reducing Animal Testing in Preclinical Safety Studies.U.S. Food and Drug Administration, April 2025
- Human Organ-on-a-Chip: benefits over animal testing, and challenges limiting adoption.GAO-25-107335, 21 May 2025
- Piergiovanni M et al. Standardisation needs for organ on chip devices.Lab on a Chip, 2021
For teams building tissue on a chip.
Six kinds of buyer who could put TissueChip.com to work, each with an example of how the address might be used.
- Well A1
Chip and device makers
A flagship brand for a company that designs and manufactures microfluidic tissue chips.
tissuechip.com/devices - Well A2
Preclinical research services
A service brand for contract studies run on tissue chips, from assay design to data delivery.
tissuechip.com/services - Well A3
Instruments and perfusion
A home for pumps, docks and imaging systems that keep chips running and measured.
tissuechip.com/instruments - Well B1
Analysis software
A product site for image analysis, sensor readouts and study data built for chip experiments.
tissuechip.com/software - Well B2
Academic cores and consortia
A shared hub for a core facility or multi-lab consortium working on tissue chip models.
tissuechip.com/consortium - Well B3
Education and news
A go-to resource that explains tissue chips to students, investors and the wider public.
tissuechip.com/learn
Align, focus, acquire.
-
Step 01Align
Send your offer
Use the form below or email directly. Every inquiry is read and answered personally within 24 hours.
-
Step 02Focus
Agree on terms
Price, payment and timing are agreed directly with the owner, with a clear written summary before anything moves.
-
Step 03Acquire
Escrow transfer
Funds are held in escrow and released only after the domain is in your registrar account and under your control.
Make an offer.
Serious offers receive a personal reply within 24 hours. Share a little about your plans for TissueChip.com. Every inquiry stays confidential.
- Email[email protected]
- ResponsePersonal reply within 24 hours
- TransferEscrow-protected
- PriceOffer-based, no fixed price
- OwnerJ Radler / Radler Boutique
Also available from the same owner: TissueChips.com and TissueOnChip.com. Acquire one or several.
Offer received.
Thank you. You will receive a personal reply within 24 hours.
Need to add something? Email [email protected]
Before you offer.
Is TissueChip.com available now, and is there a fixed price?
Yes. TissueChip.com is available now, directly from the owner. There is no fixed price: the domain is sold on an offer basis, and every serious offer gets a personal reply within 24 hours.
How does the transfer work?
Once terms are agreed, payment is placed with an escrow service. The domain is then moved into your registrar account, and the funds are released only after you confirm it is under your control.
What is a tissue chip?
A tissue chip, often called an organ-on-a-chip, is a small device with microfluidic channels lined with living cells. It is designed to mimic aspects of how a human tissue or organ works, so researchers can study biology and test compounds in the lab.
Does this page provide medical advice or lab services?
No. This is a domain sale page. It does not provide medical advice or services, and it does not sell chips, testing or research services.
How is a tissue chip different from an organoid?
An organoid is defined by its cells, which self-organise into a miniature organ. A tissue chip is defined by its device: engineered channels, flow, barriers and readouts. Organoids are often grown inside chips.
Is a tissue chip the same as an organ-on-a-chip or a tissue-on-a-chip?
In everyday use, yes. Tissue chip is the short form used by NIH and the FDA; organ-on-a-chip came from the 2010 platform paper; microphysiological system is the formal term. Tissue-on-a-chip is a longer spelling.
Can tissue chips replace animal testing?
Not today. A 2025 US Government Accountability Office assessment concluded they cannot currently replace animal testing but may be used alongside it. US law now lists organ chips among nonclinical tests, but animal tests are on the same list.
Can regulators accept tissue chip data?
A route exists. The FDA's ISTAND pilot accepts submissions to qualify drug development tools outside existing programmes, and names the use of tissue chips to assess safety or efficacy questions.
Does the name tie a buyer to one organ or one method?
No. TissueChip.com names the whole category, so it fits a single device, a multi-organ platform, a testing service or an instrument line without a later rebrand.
Why an exact-match .com rather than a coined brand?
A coined name has to be taught; a category name is already understood. People type these two words already, so the address needs no tagline.